MEDP
Undervalued by 52.9% based on the discounted cash flow analysis.
Market cap | $8.79 Billion |
---|---|
Enterprise Value | $8.47 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $13.06 |
Beta | 1.55 |
Outstanding Shares | 30,387,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 22.31 |
---|---|
PEG | 60.71 |
Price to Sales | 4.51 |
Price to Book Ratio | 16.14 |
Enterprise Value to Revenue | 4.09 |
Enterprise Value to EBIT | 19.93 |
Enterprise Value to Net Income | 23 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.34 |
No data
No data